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A report on ‘The Biology of Genomes’ meeting, Cold Spring
Harbor, USA, 10-14 May 2006.
This year, the emphasis of ‘The Biology of Genomes’ meeting
held in May at the Cold Spring Harbor Laboratory was on
the plural, with population genomics and comparative
genomics taking center stage. The initial challenge of
genomics was to efficiently generate the vast amount of data
required to assemble genome sequences, and to apply our
knowledge to sensible annotation of this deluge of data.
Although these tasks are continuing, the new challenges are
not only to scale up traditional experiments to previously
unimagined levels, but to leverage our knowledge to forge
truly new discoveries.
Next-generation DNA sequencing 
Genomics is still driven and directed by advancements and
limitations of sequencing technology. After a long incuba-
tion, the first effects of the next-generation sequencing plat-
forms are now being felt. Two new high-throughput
platforms for ultrarapid DNA sequencing were in evidence.
The GenomeSequencer 20 (GS20) platform has been devel-
oped by 454 Life Sciences (Branford, USA) and uses bead-
attached DNA fragments as templates and pyrosequencing, a
sequencing-by-synthesis technique in which the number of
incorporations of a given base is detected by the intensity of
a light signal. The Clonal Single Molecule Array platform
from Solexa, based in Little Chesterford, UK, uses amplifica-
tion of clusters of DNA fragments on glass slides and
sequencing-by-synthesis, adding one base at a time using
reversible terminators.
The driving force behind this next generation of sequencing
technology is human health, with population studies and
medical resequencing the intended applications. The
demands of these applications require a 10-100-fold increase
in throughput and a tenfold reduction in cost. Jane Rogers
(The Wellcome Trust Sanger Institute, Hinxton, UK) pre-
sented results from a trial of the GS20 and Solexa technolo-
gies at the Sanger Centre, in which both performed
successfully in sequencing bacterial genomes and in the
sequencing of the human major histocompatibility complex
genomic regions cloned in bacterial artificial chromosomes
(BACs) - representing a medical resequencing application.
Comparisons with clone-based sequencing by the conven-
tional Sanger method showed that both the new platforms
have difficulty with rRNA repeats, whereas small genes with
strong promoters may be missed from the Sanger-type
clone-based sequencing. 
Future applications of these technologies were suggested in
two talks on work that utilized the GS20 platform. In a study
of idiopathic generalized epilepsy, John McPherson (Baylor
College of Medicine, Houston, USA) reported on the rese-
quencing for medical purposes of 250 ion-channel genes
from 500 cases and 500 controls that identified nearly 900
nonsynonymous single-nucleotide polymorphisms (SNPs),
75% of which were novel. The sequence dataset was gener-
ated from pooled samples from 250 individuals that were
PCR-amplified for 50 loci and sequenced on the GS20 plat-
form in one run. This approach has uncovered functional
variation in known epilepsy genes and it is hoped that it will
help identify individuals who carry multiple rare alleles that
may interact to cause the disease.
Ramy Arnaout (Brigham and Women’s Hospital, Broad
Institute and Harvard University, Boston, USA) presented a
study using the GS20 platform to investigate the variability
in the genomic rearrangements that generate complete
immunoglobulin genes during B-cell development. By using
multiplex PCR and primers, all rearrangements of V, D and J
gene segments in an individual’s B-cells could be identified
by 200 bp reads generated on the GS20 sequencer. In
healthy unimmunized people, variation between individuals
was found to be similar to that within an individual over theseveral months duration of the study, and this technique is
being applied to identifying VDJ profiles in T-cells and
B-cells associated with disease and vaccination.
Making sense of SNPs 
The most recent inrush of genomic data has come from the
HapMap project, which aims to identify and map all the
SNPs present in the human population, thus providing an
unrivaled set of markers for identifying disease-causing
genes. Several talks discussed the analysis methods, applica-
tions and technical platforms that are needed to take advan-
tage of these data.
The huge increase in the number of data points that can be
used to map disease genes has created new statistical issues
in analysis. One approach to mitigating the challenging mul-
tiple testing problems inherent in large SNP studies was pre-
sented by Kathryn Roeder (Carnegie Mellon University,
Pennsylvania, USA), who advocated using weights both in
analysis and incorporated into the experimental design. The
applications of mapping disease genes by identifying shared
haplotypes in case-control studies was presented by Ingileif
Hallgrímsdóttir (University of Oxford, UK). This involves
inferring co-inheritance alleles from a parent using haplo-
type data and identifying the haplotypes shared between
affected individuals and absent in non affected controls, and
provides another method for digging through the rising
mountain of genotype data.
The new powerful tools for assessing variation will undoubt-
edly lead to a dramatic surge in the number of new associa-
tions between genes and diseases. The large amount of
genotyping data generated by the HapMap project also fea-
tured in projects to identify inversion polymorphisms; to
map gene-expression variation as quantitative traits; to
analyze human demographic history; to detect regions under
recent positive selection; and to analyze the effect of
sequence variation on splicing. 
Functional genomics: an extra dimension 
The availability of genome sequences has triggered a wave of
functional genomic studies aimed at experimentally verify-
ing and enriching genome annotation and understanding
how genome sequence relates to whole-organism biology. In
order to deal with this large volume of functional data and
integrate it with genomic data, data standards and sophisti-
cated storage methods are required.
The most visually spectacular talk of the conference was a
presentation by Angela DePace (Lawrence Berkeley National
Laboratory, Berkeley, USA) on the three-dimensional atlas
of gene expression in Drosophila. The three-dimensional
atlas is based on the confocal imaging of many independent
gene-expression experiments in whole-mount Drosophila
embryos. The data are converted to a point cloud coordinate
system, which enables virtual integration of the results of the
different experiments, and the result is a three-dimensional
display of the simultaneous expression patterns of multiple
genes. A comparable system was presented by John Murray
(University of Washington School of Medicine, Seattle, USA)
for Caenorhabditis, which has the advantage of a complete
cell-fate map on which to integrate the data. Although this
approach is still in the early stages of development, similar
methods will undoubtedly be able to provide the same sort of
information-rich resources for developmental genomics in
other model species. 
Proteins were not neglected at the meeting. An attempt to
develop antibodies to the products of all predicted human
genes and use these to analyze tissue arrays of 48 normal
and 20 cancer tissues was presented by Mathias Uhlén
(Royal Institute of Technology, Stockholm, Sweden) as ‘The
Protein Atlas’. Annotation by expert pathologists and the
availability of the affinity-purified polyclonal antibodies to
researchers promise to make this a valuable resource as it
grows to cover more of the genome. 
Lessons from comparative genomics 
The main contribution of comparative genomics has been to
identify functional regions of the genome by their sequence
conservation. With a multitude of sequenced genomes now
available, the ability to analyze changes in these conserved
elements among species has expanded. Adam Siepel (Cornell
University, Ithaca, USA) presented an analysis of lineage-
specific conserved elements in the 1% of the genome covered
by the ENCODE project. Using a phylogenetic hidden
Markov model program, Siepel has identified elements that
cover about 5% of the ENCODE regions. A quarter of these
elements vary among the mammalian lineages, with more
losses than gains and a large number of gains on the lineage
leading to eutherian mammals.
With the evolutionary history of the genome playing such a
major role in its current function, easy access to the recon-
structed ancestors of current genomes will be an important
aid to interpretation. David Haussler (University of Cali-
fornia, Santa Cruz, USA) introduced plans for a large
multi-group effort to reconstruct the history of the eutherian
genome, by modeling both large scale rearrangements and
substitutions and computing over all possible evolutionary
histories. This could rapidly evolve into a new and valuable
resource. 
The origin, evolution and function of ultraconserved ele-
ments is one of the enigmas to arise from large-scale com-
parative genomics. Gill Bejerano (University of California,
Santa Cruz, USA), described how an ancient short inter-
spersed nuclear repeat element (SINE) has been recruited as
both an exon and a distal enhancer. The SINE that is found
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enhancer of the ISL1 gene in mammals. In reporter assays this
element recapitulates the ISL1 gene’s neural expression
pattern. The same SINE also acts as an alternatively spliced
exon of another mammalian gene, PCBP2. This work provides
an interesting example of possible ‘exaptation’, the situation
whereby fortuitously distributed identical elements appear to
have been co-opted to provide new multigene regulatory net-
works for existing genes. On a more practical front, it may also
highlight the need for a more cautious approach to the
common practice of masking and subsequent removal of large
numbers of repeated elements from genomic analyses.
The usefulness of comparative genomics of domestic
animals for mapping traits was apparent in several talks.
Leif Andersson (Uppsala University, Uppsala, Sweden) pre-
sented a study in which melanocyte migration defects were
rapidly mapped using dog breeds, highlighting the benefits
of population structure, strong selection and closely moni-
tored phenotypes of domestic animals in disease gene
mapping. Michel Georges (University of Liège, Belgium)
described work on quantitative traits affecting myogenesis in
Texel sheep. His identification of a SNP in the 3’ untrans-
lated region of the MSTN gene that accounts for up to 20%
of the muscle-trait variation is of particular interest as it
joins an exclusive, but growing, group of mutations that
produce a phenotype by disrupting the interactions of
microRNAs (miRNAs) with genes. This particular miRNA
interaction inhibits the translation of the protein but not the
abundance of the mRNA transcript.
Additional species continue to be added to the comparative
genomics repertoire. Proving that extinction need not be a
barrier to inclusion, Svante Pääbo (Max Planck Institute for
Evolutionary Anthropology, Leipzig, Germany) showed how
the Pleistocene has contributed genomic information from
mammoths, cave bears and Neanderthals. The small amount
of data available so far indicate that Neanderthals diverged
from modern humans (Homo sapiens) 400,000 years ago
and that there was separation of the gene pools.
Progress on the sequencing and analysis of the opossum
genome was presented by Kerstin Lindblad-Toh (Broad Insti-
tute, Boston, USA), and among the many meetings of small
groups of researchers throughout the conference was one of
the platypus genome sequencing consortium, indicating that
next year will be an exciting one for comparative genomics.
The power of large-scale comparisons remains the core of
genomics. This meeting emphasized that comparisons are
beginning to reveal unexpected secrets of the genome and its
evolutionary history. In the nearer future, however, there is
the promise of using high-throughput capability to assess
variation in the human population and gain fresh insights
into disease.
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